Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishment of a novel indicator of pyroptosis regulated gene transcription level and its application in pan-cancer. | Sci Rep | 2023 | 37863886 | PubTator, text mining | PubMed |
| Non-metabolic enzyme function of PKM2 in hepatocellular carcinoma: A review. | Medicine (Baltimore) | 2023 | 37861491 | PubTator, text mining | PubMed |
| MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis. | Front Oncol | 2023 | 37854681 | PubTator, text mining | PubMed |
| Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual. | iScience | 2023 | 37841584 | PubTator, text mining | PubMed |
| H1Innovative approaches to combat anti-cancer drug resistance: Targeting lncRNA and autophagy. | Clin Transl Med | 2023 | 37837401 | PubTator, text mining | PubMed |
| Epigenetic Modulators as Therapeutic Agents in Cancer. | Int J Mol Sci | 2023 | 37834411 | PubTator, text mining | PubMed |
| CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation. | Int J Mol Sci | 2023 | 37834313 | PubTator, text mining | PubMed |
| Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases. | Int J Mol Sci | 2023 | 37834214 | PubTator, text mining | PubMed |
| Histone and Histone Acetylation-Related Alterations of Gene Expression in Uninvolved Psoriatic Skin and Their Effects on Cell Proliferation, Differentiation, and Immune Responses. | Int J Mol Sci | 2023 | 37833997 | PubTator, text mining | PubMed |
| Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines. | Int J Mol Sci | 2023 | 37833990 | PubTator, text mining | PubMed |
| Heterozygous loss-of-function SMC3 variants are associated with variable and incompletely penetrant growth and developmental features. | medRxiv | 2023 | 37808847 | PubTator, text mining | PubMed |
| Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma. | BMC Cancer | 2023 | 37789275 | PubTator, text mining | PubMed |
| Intrinsic structural dynamics dictate enzymatic activity and inhibition. | Proc Natl Acad Sci U S A | 2023 | 37782780 | PubTator, text mining | PubMed |
| Inhibition of Heat Shock-Induced H3K9ac Reduction Sensitizes Cancer Cells to Hyperthermia. | Int J Biol Sci | 2023 | 37781518 | PubTator, text mining | PubMed |
| AURKA inhibitor-induced PD-L1 upregulation impairs antitumor immune responses. | Front Immunol | 2023 | 37781397 | PubTator, text mining | PubMed |
| Molecular Dynamics Simulations of HDAC-ligand Complexes Towards the Design of New Anticancer Compounds. | Curr Top Med Chem | 2023 | 37779411 | PubTator, text mining | PubMed |
| Anti-Colorectal Cancer Activity of Solasonin from Solanum nigrum L. via Histone Deacetylases-Mediated p53 Acetylation Pathway. | Molecules | 2023 | 37764423 | PubTator, text mining | PubMed |
| Modulation of Notch Signaling by Small-Molecular Compounds and Its Potential in Anticancer Studies. | Cancers (Basel) | 2023 | 37760535 | PubTator, text mining | PubMed |
| The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). | Cancers (Basel) | 2023 | 37760523 | PubTator, text mining | PubMed |
| Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes. | Cells | 2023 | 37759468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=14